VAERS reports by lot

Merck Pneumococcal lot R033343: VAERS reports

43 VAERS reports list lot R033343 as a Merck Pneumococcal vaccine, received between 2019-02-21 and 2021-08-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
5%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction6341%
Allergic / Anaphylactic1711%
Musculoskeletal1711%
General / Systemic (non-local)1611%
Neurological149%
Cardiac / Cardiovascular128%
Dermatological (non-injection-site)85%
Respiratory32%
Gastrointestinal21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California9
Texas4
Oregon3
Colorado3
New Jersey2
New York2
North Carolina2
Connecticut2
Georgia2
South Carolina1
New Hampshire1
Washington1

Reports by month received

2019-021
2019-035
2019-049
2019-054
2019-066
2019-072
2019-083
2019-093
2019-103
2019-111
2019-122
2020-031
2020-051
2020-111
2021-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.